Evidence map›Paper›PMID 28638711›Full record

SynthesisBrain and behavior2017

Decrease in brain-derived neurotrophic factor at plasma level but not in serum concentrations in suicide behavior: A systematic review and meta-analysis.

Marisol Salas-Magaña, Carlos A Tovilla-Zárate, Thelma B González-Castro, Isela E Juárez-Rojop, María L López-Narváez, José M Rodríguez-Pérez, Julián Ramírez Bello

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Brain and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional dysfunction superspectrum.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Examination of pain threshold and neuropeptides in patients with acute suicide risk.Progress in neuro-psychopharmacology & biological psychiatry · 2019
    Article
  16. Article
  17. Annual Research Review: Suicide among youth - epidemiology, (potential) etiology, and treatment.Journal of child psychology and psychiatry, and allied disciplines · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Marisol Salas-MagañaDivisión Académica de Ciencias de la Salud Universidad Juárez Autónoma de Tabasco Villahermosa Tabasco México.
Carlos A Tovilla-ZárateDivisión Académica Multidisciplinaria de Comalcalco Universidad Juárez Autónoma de Tabasco Comalcalco Tabasco México.ORCID 0000-0001-8170-8171
Thelma B González-CastroDivisión Académica Multidisciplinaria de Jalpa de Méndez Universidad Juárez Autónoma de Tabasco Jalpa de Méndez Tabasco México.
Isela E Juárez-RojopDivisión Académica de Ciencias de la Salud Universidad Juárez Autónoma de Tabasco Villahermosa Tabasco México.ORCID 0000-0003-3760-7394
María L López-NarváezHospital General de Yajalón Secretaría de Salud Yajalón Chiapas México.
José M Rodríguez-PérezDepartamento de Biología Molecular Instituto Nacional de Cardiología Ignacio Chávez Ciudad de México México.
Julián Ramírez BelloUnidad de Investigación Hospital Juárez de México Secretaría de Salud Ciudad de México México.
Universidad Juárez Autónoma de Tabasco · MXHospital Juárez de México · MXSecretaria de Salud · HN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSuicide is known as a major health concern worldwide. There is evidence for the role of brain-derived neurotrophic factor (BDNF) in suicide behavior. Therefore, this factor has been proposed as a biomarker for suicide behavior. Clinical studies have measured BDNF concentrations at central and peripheral levels. As a consequence, the aim of this study was to assess BDNF levels in blood plasma and serum to see whether there is a difference in concentrations in patients with suicide behavior when compared to those in controls, using a meta-analysis approach.

methodsWe conducted a systematic review and meta-analysis. The search strategy was performed using three databases: PubMed, EBSCO and ScienceDirect. The meta-analysis included a total of nine case-control studies, six measured the BDNF level in serum and three in plasma in suicide behavior.

resultsA decrease in BDNF levels in plasma was observed (

conclusionsAccording to the results found in the present meta-analysis, the plasma BDNF level could be suggest as a potential biomarker in suicide behavior. However, since the number of studies included in the analysis is limited, a larger number is necessary to determine conclusively the role of BDNF as a biomarker in suicide behavior.

Indexed as

Brain-Derived Neurotrophic FactorSuicideBehavioral SymptomsBiomarkersHumansBiomarkersBrain-Derived Neurotrophic FactorBrain‐derived neurotrophic factorplasmaserumsuicide

Identifiers

PMID28638711
PMCPMC5474709
OpenAlexW2605853784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.